Home » NJ Pharmaceutical Companies Lead Development of New Hepatitis C Treatment
NJ Pharmaceutical Companies Lead Development of New Hepatitis C Treatment
At Fred Poordad’s bustling hepatitis C clinic in the heart of Los Angeles, one in every five patients receives no treatment.
Star-Ledger
Star-Ledger
Upcoming Events
-
07May
-
14May
-
30May